REPLIGEN CORP Investing Cash Flow
REPLIGEN CORP (RGEN) reported Investing Cash Flow of -$6.08 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-29
- REPLIGEN CORP net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$2.09M.
- REPLIGEN CORP net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$3.99M.
- REPLIGEN CORP net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$208.74M.
- REPLIGEN CORP net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$7.78M.
- REPLIGEN CORP net cash provided by (used in) investing activities for fiscal 2025 was -$298.47M.
- REPLIGEN CORP net cash provided by (used in) investing activities for fiscal 2024 was -$86.38M.
- REPLIGEN CORP net cash provided by (used in) investing activities for fiscal 2023 was -$123.28M.
- REPLIGEN CORP net cash provided by (used in) investing activities for fiscal 2022 was -$233.24M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$6.08M 10-Q · filed 2026-07-29 | -$214.82M derived: sum of 3 quarters · filed 2026-07-29 | -$222.60M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$3.99M 10-Q · filed 2026-05-06 | -$212.73M derived: sum of 2 quarters · filed 2026-05-06 | -$220.51M derived: sum of 3 quarters · filed 2026-05-06 | -$228.35M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | -$208.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$216.53M derived: sum of 2 quarters · filed 2026-02-26 | -$224.37M derived: sum of 3 quarters · filed 2026-07-29 | -$298.47M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$7.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$15.62M derived: sum of 2 quarters · filed 2026-07-29 | -$89.73M 10-Q · filed 2025-11-04 | -$154.49M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | -$7.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$81.95M 10-Q · filed 2026-07-29 | -$146.71M derived: sum of 3 quarters · filed 2026-07-29 | -$152.57M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$74.11M 10-Q · filed 2026-05-06 | -$138.87M derived: sum of 2 quarters · filed 2026-05-06 | -$144.73M derived: sum of 3 quarters · filed 2026-05-06 | -$152.13M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$64.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$70.62M derived: sum of 2 quarters · filed 2026-02-26 | -$78.02M derived: sum of 3 quarters · filed 2026-02-26 | -$86.38M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$5.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$13.26M derived: sum of 2 quarters · filed 2025-11-04 | -$21.62M 10-Q · filed 2025-11-04 | -$191.53M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$7.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$15.76M 10-Q · filed 2025-08-07 | -$185.67M derived: sum of 3 quarters · filed 2026-02-26 | -$194.44M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$8.36M 10-Q · filed 2025-04-29 | -$178.27M derived: sum of 2 quarters · filed 2026-02-26 | -$187.04M derived: sum of 3 quarters · filed 2026-02-26 | -$122.20M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$169.91M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-26 | -$178.68M derived: sum of 2 quarters · filed 2026-02-26 | -$113.84M derived: sum of 3 quarters · filed 2026-02-26 | -$123.28M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$8.77M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | $56.06M derived: sum of 2 quarters · filed 2024-11-18 | $46.63M 10-Q/A · filed 2024-11-18 | -$74.68M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-06-30 | $64.83M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | $55.40M 10-Q/A · filed 2024-11-18 | -$65.91M derived: sum of 3 quarters · filed 2025-03-14 | -$123.40M derived: sum of 4 quarters · filed 2025-03-14 |
| 2023-03-31 | -$9.43M 10-Q/A · filed 2024-11-18 | -$130.74M derived: sum of 2 quarters · filed 2025-03-14 | -$188.24M derived: sum of 3 quarters · filed 2025-03-14 | -$214.46M derived: sum of 4 quarters · filed 2025-03-14 |
| 2022-12-31 | -$121.31M derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-03-14 | -$178.80M derived: sum of 2 quarters · filed 2025-03-14 | -$205.02M derived: sum of 3 quarters · filed 2025-03-14 | -$233.24M 10-K · filed 2025-03-14 |
| 2022-09-30 | -$57.49M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2024-11-18 | -$83.71M derived: sum of 2 quarters · filed 2024-11-18 | -$111.93M 10-Q/A · filed 2024-11-18 | -$174.20M derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-06-30 | -$26.22M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2024-11-18 | -$54.43M 10-Q/A · filed 2024-11-18 | -$116.71M derived: sum of 3 quarters · filed 2024-11-18 | -$249.41M derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-03-31 | -$28.21M 10-Q/A · filed 2024-11-18 | -$90.49M derived: sum of 2 quarters · filed 2024-11-18 | -$223.19M derived: sum of 3 quarters · filed 2024-11-18 | -$240.39M derived: sum of 4 quarters · filed 2024-11-18 |
| 2021-12-31 | -$62.28M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | -$194.97M derived: sum of 2 quarters · filed 2024-11-18 | -$212.17M derived: sum of 3 quarters · filed 2024-11-18 | -$221.17M 10-K/A · filed 2024-11-18 |
| 2021-09-30 | -$132.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$149.90M derived: sum of 2 quarters · filed 2022-11-01 | -$158.89M 10-Q · filed 2022-11-01 | -$317.18M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | -$17.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$26.20M 10-Q · filed 2022-08-02 | -$184.49M derived: sum of 3 quarters · filed 2023-02-22 | -$218.07M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | -$9.00M 10-Q · filed 2022-04-27 | -$167.28M derived: sum of 2 quarters · filed 2023-02-22 | -$200.87M derived: sum of 3 quarters · filed 2023-02-22 | -$205.34M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | -$158.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$191.87M derived: sum of 2 quarters · filed 2023-02-22 | -$196.35M derived: sum of 3 quarters · filed 2023-02-22 | -$201.38M 10-K · filed 2023-02-22 |
| 2020-09-30 | -$33.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | -$38.06M derived: sum of 2 quarters · filed 2021-10-28 | -$43.10M 10-Q · filed 2021-10-28 | -$50.21M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-30 | -$4.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | -$9.52M 10-Q · filed 2021-07-27 | -$16.63M derived: sum of 3 quarters · filed 2022-02-17 | -$23.52M derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-31 | -$5.04M 10-Q · filed 2021-05-04 | -$12.15M derived: sum of 2 quarters · filed 2022-02-17 | -$19.04M derived: sum of 3 quarters · filed 2022-02-17 | -$206.52M derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-31 | -$7.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$14.00M derived: sum of 2 quarters · filed 2022-02-17 | -$201.48M derived: sum of 3 quarters · filed 2022-02-17 | -$205.31M 10-K · filed 2022-02-17 |
| 2019-09-30 | -$6.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$194.37M derived: sum of 2 quarters · filed 2020-11-05 | -$198.20M 10-Q · filed 2020-11-05 | -$203.65M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | -$187.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$191.31M 10-Q · filed 2020-07-30 | -$196.76M derived: sum of 3 quarters · filed 2021-02-24 | -$200.93M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | -$3.83M 10-Q · filed 2020-05-06 | -$9.29M derived: sum of 2 quarters · filed 2021-02-24 | -$13.45M derived: sum of 3 quarters · filed 2021-02-24 | -$16.30M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | -$5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$9.63M derived: sum of 2 quarters · filed 2021-02-24 | -$12.47M derived: sum of 3 quarters · filed 2021-02-24 | -$14.04M 10-K · filed 2021-02-24 |
| 2018-09-30 | -$4.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$7.02M derived: sum of 2 quarters · filed 2019-10-31 | -$8.58M 10-Q · filed 2019-10-31 | -$10.20M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | -$2.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$4.41M 10-Q · filed 2019-08-01 | -$6.03M derived: sum of 3 quarters · filed 2020-02-26 | -$117.24M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | -$1.56M 10-Q · filed 2019-05-09 | -$3.19M derived: sum of 2 quarters · filed 2020-02-26 | -$114.39M derived: sum of 3 quarters · filed 2020-02-26 | |
| 2017-12-31 | -$1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$112.83M derived: sum of 2 quarters · filed 2020-02-26 | -$98.70M 10-K · filed 2020-02-26 | |
| 2017-09-30 | -$111.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$97.08M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | $14.13M 10-Q · filed 2018-08-02 | |||
| 2016-12-31 | -$49.19M 10-K · filed 2019-03-01 | |||
| 2013-12-31 | -$10.03M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | -$12.10M derived: sum of 2 quarters · filed 2014-03-14 | -$12.86M derived: sum of 3 quarters · filed 2014-03-14 | -$17.91M 10-K · filed 2014-03-14 |
| 2013-09-30 | -$2.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$2.83M derived: sum of 2 quarters · filed 2013-11-08 | -$7.88M 10-Q · filed 2013-11-08 | -$4.74M derived: sum of 4 quarters · filed 2014-03-14 |
| 2013-06-30 | -$761.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$5.81M 10-Q · filed 2013-08-07 | -$2.67M derived: sum of 3 quarters · filed 2014-03-14 | -$3.96M derived: sum of 4 quarters · filed 2014-03-14 |
| 2013-03-31 | -$5.05M 10-Q · filed 2013-05-07 | -$1.91M derived: sum of 2 quarters · filed 2014-03-14 | -$3.20M derived: sum of 3 quarters · filed 2014-03-14 | -$1.82M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-12-31 | $3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $1.85M derived: sum of 2 quarters · filed 2014-03-14 | $3.23M derived: sum of 3 quarters · filed 2014-03-14 | $2.84M 10-K · filed 2014-03-14 |
| 2012-09-30 | -$1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $86.53K derived: sum of 2 quarters · filed 2013-11-08 | -$299.37K 10-Q · filed 2013-11-08 | -$4.50M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $992.77K 10-Q · filed 2013-08-07 | -$3.21M derived: sum of 3 quarters · filed 2014-03-14 | $8.52K derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | -$385.90K 10-Q · filed 2013-05-07 | -$4.59M derived: sum of 2 quarters · filed 2014-03-14 | -$1.37M derived: sum of 3 quarters · filed 2014-03-14 | -$5.40M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | -$4.20M derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14 | -$984.25K derived: sum of 2 quarters · filed 2014-03-14 | -$5.01M 10-K · filed 2014-03-14 | -$2.03M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-09-30 | $3.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09 | -$810.09K 10-Q · filed 2011-11-09 | $2.17M 10-Q · filed 2012-11-08 | -$4.25M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-06-30 | -$4.03M 10-Q · filed 2011-08-05 | -$1.04M 10-Q · filed 2012-08-09 | -$7.47M derived: sum of 3 quarters · filed 2014-03-14 | -$1.78M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-03-31 | $2.98M 10-Q · filed 2012-05-10 | -$3.44M derived: sum of 2 quarters · filed 2014-03-14 | $2.24M derived: sum of 3 quarters · filed 2014-03-14 | -$1.50M 10-K · filed 2013-03-15 |
| 2010-12-31 | -$6.43M derived: 10-K 9 month − 10-Q 6 month · filed 2014-03-14 | -$739.67K derived: sum of 2 quarters · filed 2014-03-14 | -$4.49M 10-K · filed 2014-03-14 | |
| 2010-09-30 | $5.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-09 | $1.94M 10-Q · filed 2011-11-09 | ||
| 2010-06-30 | -$3.75M 10-Q · filed 2011-08-05 | |||
| 2010-03-31 | $9.92M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |